228 related articles for article (PubMed ID: 32622826)
21. Downstaging prior to liver transplantation for hepatocellular carcinoma: advisable but at the price of an increased risk of cancer recurrence - a retrospective study.
Toso C; Meeberg G; Andres A; Shore C; Saunders C; Bigam DL; Shapiro AMJ; Compagnon P; Berney T; Majno P; Kneteman N
Transpl Int; 2019 Feb; 32(2):163-172. PubMed ID: 30152891
[TBL] [Abstract][Full Text] [Related]
22. Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial.
Mazzaferro V; Citterio D; Bhoori S; Bongini M; Miceli R; De Carlis L; Colledan M; Salizzoni M; Romagnoli R; Antonelli B; Vivarelli M; Tisone G; Rossi M; Gruttadauria S; Di Sandro S; De Carlis R; Lucà MG; De Giorgio M; Mirabella S; Belli L; Fagiuoli S; Martini S; Iavarone M; Svegliati Baroni G; Angelico M; Ginanni Corradini S; Volpes R; Mariani L; Regalia E; Flores M; Droz Dit Busset M; Sposito C
Lancet Oncol; 2020 Jul; 21(7):947-956. PubMed ID: 32615109
[TBL] [Abstract][Full Text] [Related]
23. Role of selected criteria and preventive chemotherapy in tumor recurrence after liver transplantation.
Wang MX; Chen D; Zhao YY; Yang B; Jiang JP; Zeng FJ; Wei L; Chen ZS
Hepatobiliary Pancreat Dis Int; 2020 Aug; 19(4):378-383. PubMed ID: 32622825
[TBL] [Abstract][Full Text] [Related]
24. Transarterial chemoinfusion for hepatocellular carcinoma as downstaging therapy and a bridge toward liver transplantation.
De Luna W; Sze DY; Ahmed A; Ha BY; Ayoub W; Keeffe EB; Cooper A; Esquivel C; Nguyen MH
Am J Transplant; 2009 May; 9(5):1158-68. PubMed ID: 19344435
[TBL] [Abstract][Full Text] [Related]
25. Liver Resection and Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria.
Zaydfudim VM; Vachharajani N; Klintmalm GB; Jarnagin WR; Hemming AW; Doyle MB; Cavaness KM; Chapman WC; Nagorney DM
Ann Surg; 2016 Oct; 264(4):650-8. PubMed ID: 27433910
[TBL] [Abstract][Full Text] [Related]
26. Downstaging advanced hepatocellular carcinoma to the Milan criteria may provide a comparable outcome to conventional Milan criteria.
Lei J; Wang W; Yan L
J Gastrointest Surg; 2013 Aug; 17(8):1440-6. PubMed ID: 23719776
[TBL] [Abstract][Full Text] [Related]
27. Liver transplantation beyond or downstaging within the Milan criteria for hepatocellular carcinoma.
Rudnick SR; Russo MW
Expert Rev Gastroenterol Hepatol; 2018 Mar; 12(3):265-275. PubMed ID: 29231769
[TBL] [Abstract][Full Text] [Related]
28. Liver Transplantation for Hepatocellular Carcinoma Beyond the Milan Criteria.
Gunsar F
Exp Clin Transplant; 2017 Mar; 15(Suppl 2):59-64. PubMed ID: 28302001
[TBL] [Abstract][Full Text] [Related]
29. Downstaging hepatocellular carcinoma: A systematic review and pooled analysis.
Parikh ND; Waljee AK; Singal AG
Liver Transpl; 2015 Sep; 21(9):1142-52. PubMed ID: 25981135
[TBL] [Abstract][Full Text] [Related]
30. Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium.
Agopian VG; Harlander-Locke MP; Ruiz RM; Klintmalm GB; Senguttuvan S; Florman SS; Haydel B; Hoteit M; Levine MH; Lee DD; Taner CB; Verna EC; Halazun KJ; Abdelmessih R; Tevar AD; Humar A; Aucejo F; Chapman WC; Vachharajani N; Nguyen MH; Melcher ML; Nydam TL; Mobley C; Ghobrial RM; Amundsen B; Markmann JF; Langnas AN; Carney CA; Berumen J; Hemming AW; Sudan DL; Hong JC; Kim J; Zimmerman MA; Rana A; Kueht ML; Jones CM; Fishbein TM; Busuttil RW
Ann Surg; 2017 Sep; 266(3):525-535. PubMed ID: 28654545
[TBL] [Abstract][Full Text] [Related]
31. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.
Hanouneh IA; Macaron C; Lopez R; Aucejo F; Zein NN
Transplant Proc; 2011 Dec; 43(10):3813-8. PubMed ID: 22172852
[TBL] [Abstract][Full Text] [Related]
32. Predictors of outcome after liver transplantation for hepatocellular carcinoma (HCC) beyond Milan criteria.
Halazun KJ; Sapisochin G; von Ahrens D; Agopian VG; Tabrizian P
Int J Surg; 2020 Oct; 82S():61-69. PubMed ID: 32707331
[TBL] [Abstract][Full Text] [Related]
33. Reappraisal of Failures in Downstaging Treatment of Hepatocellular Carcinoma Prior to Liver Transplant-Preliminary Report on the Impact of Underestimations of Tumor Numbers and Tumor Sizes as Measured From Imaging Before Transplant.
Jeng KS; Huang CC; Lin CK; Lin CC; Huang CT; Chung CS; Weng MT; Chen KH
Transplant Proc; 2019 Jun; 51(5):1428-1434. PubMed ID: 31079940
[TBL] [Abstract][Full Text] [Related]
34. Benefit of downsizing hepatocellular carcinoma in a liver transplant population.
Jang JW; You CR; Kim CW; Bae SH; Yoon SK; Yoo YK; Kim DG; Choi JY
Aliment Pharmacol Ther; 2010 Feb; 31(3):415-23. PubMed ID: 19821808
[TBL] [Abstract][Full Text] [Related]
35. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.
Yao FY; Hirose R; LaBerge JM; Davern TJ; Bass NM; Kerlan RK; Merriman R; Feng S; Freise CE; Ascher NL; Roberts JP
Liver Transpl; 2005 Dec; 11(12):1505-14. PubMed ID: 16315294
[TBL] [Abstract][Full Text] [Related]
36. Hepatocellular carcinoma downstaging in liver transplantation.
Yu CY; Ou HY; Huang TL; Chen TY; Tsang LL; Chen CL; Cheng YF
Transplant Proc; 2012 Mar; 44(2):412-4. PubMed ID: 22410030
[TBL] [Abstract][Full Text] [Related]
37. Liver transplantation in hepatocellular carcinoma - should we perform downstaging?
Filipec Kanižaj T; Dinjar Kujundžić P; Ostojić A; Mijić M; Sertić Milić H; Mijić A; Mateljak M; Martinčević D; Radetić E; Vidjak V; Kocman B; Mikolašević I
Croat Med J; 2022 Aug; 63(4):317-325. PubMed ID: 36046928
[TBL] [Abstract][Full Text] [Related]
38. Impact of Brazilian expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a multicenter study.
Chagas AL; Mattos AA; Diniz MA; Felga GEG; Boin IFSF; Silva RCMA; Silva RF; Garcia JHP; Lima AS; Coelho JCU; Bittencourt PL; Alves VAF; D'Albuquerque LAC; Carrilho FJ;
Ann Hepatol; 2021; 22():100294. PubMed ID: 33276136
[TBL] [Abstract][Full Text] [Related]
39. Expansion of the Milan criteria without any sacrifice: combination of the Hangzhou criteria with the pre-transplant platelet-to-lymphocyte ratio.
Xia W; Ke Q; Guo H; Wang W; Zhang M; Shen Y; Wu J; Xu X; Yan S; Yu J; Zhang M; Zheng S
BMC Cancer; 2017 Jan; 17(1):14. PubMed ID: 28056901
[TBL] [Abstract][Full Text] [Related]
40. Clinical profile and liver explant findings in patients with and without pretransplant downstaging for hepatocellular carcinoma.
Felga G; Evangelista AS; Salvalaggio PR; Curvelo LA; Della Guardia B; Almeida MD; Afonso RC; Ferraz-Neto BH
Transplant Proc; 2012 Oct; 44(8):2399-402. PubMed ID: 23026605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
